Table 2. Diagnosis and treatment of TB.

	TB lesions (organ, locations)	TB-Ab	T-SPOT	TB confirmation	Calcification	TB cavity	Active/latent TB	TB treatment	Follow-up* (months)
P1	Lung, bilateral diffuse lesions	(+)	(+)	Sputum AFB (+)	No	Yes	Active	4HREZ/4PaReEZLfx	4.2
P2	Lung, left upper	NS	NS	History + radiology	Yes	No	Latent	NS	17.3
P3	Lung, right lower	(–)	(–)	Resected tissue AFB (+)	Yes	No	Active	2HRELfx/4HR	1.5
P4	Lung, bilateral upper and right lower	NS	NS	History + radiology	No	No	Latent	2HREZ/4HR	8.1
P5	Lung, bilateral upper	NS	NS	History + radiology	No	No	Latent	2HREZ/4HR	12.0
P6	Lung, bilateral upper and right lower	NS	NS	History + radiology	No	No	Latent	2HREZ/4HR	1.8
P7	Lung, left upper	(+)	NS	History + radiology	No	No	Latent	naïve	7.2
P8	Lung, bilateral upper	(–)	(+)	History + radiology	Yes	Yes	Latent	naïve	5.7
P9	Lung, right upper	(–)	NS	History + radiology	No	No	Latent	NS	9.3
P10	Pleura, left lower	NS	NS	History + radiology	Yes	No	Latent	3HREZ/9HR	21.5
P11	Lung, right upper	NS	NS	History + radiology	Yes	No	Latent	2HREZ/4HR	3.7
P12	Bone, left hip joint	(–)	(–)	History	NS	NS	Latent	3HREZ/9HR	18.4
P13	Lung, left upper	(–)	(+)	History + radiology	Yes	No	Latent	NS	23.8

Follow-up*, the time from ICI initiation to the last chest CT with confirmation that there was no deterioration of active TB or reactivation of latent TB at that point of time. TB, tuberculosis; Ab, antibody; NS, not specified; AFB, acid-fast bacillus; H, isoniazid; R, rifampicin; E, ethambutol; Z, pyrazinamide; Pa, pasiniazid; Re, rifapentine; Lfx, levofloxacin.